BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
- Status
- RECRUITING
- Phase
- N/A
National Cancer Institute "Cancer Moonshot Biobank"
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Evaluation Study on Performance of Guided Clinical Pharmacy Consultation in Patients With Multiple Myeloma on First Oral Anticancer Treatment
- Status
- COMPLETED
- Phase
- NA
Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- NA
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of CAR-T Therapy in Older Patients
- Status
- RECRUITING
- Phase
- N/A
The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma
- Status
- SUSPENDED
- Phase
- NA
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1
Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE3
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Phase II Study in Elderly Patients With Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3602 Capsule
- Status
- UNKNOWN
- Phase
- PHASE1
Bone Pain in Multiple Myeloma- a Translational Study
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Effect of Sleep Quality on Hematopoietic Cell Transplant Patient Outcomes
- Status
- TERMINATED
- Phase
- NA
BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2